Patients with advanced triple negative breast cancer ineligible for immunotherapy may overcome their typically poor prognosis with antibody-drug conjugates, suggest two trials presented at ESMO 2025.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/two-adcs-offer-more-hope-patients-advanced-tnbc-2025a1000t82?src=rss
Author :
Publish date : 2025-10-27 14:25:00
Copyright for syndicated content belongs to the linked Source.
